论文部分内容阅读
感染仍然是烧伤病人发病率和死亡率最常见的原因,自1973年确定磺胺嘧啶银(Ag-SD)的抗感染作用以来,Ag-SD局部抗感染治疗在预防烧伤创面感染方面起着主要作用。其全身性副作用就是用药早期出现的暂时性白细胞减少症(SAL)。然而SAL的定义至今未确立。因
Infection remains the most common cause of morbidity and mortality in burns patients, and Ag-SD topical anti-infective therapy plays a major role in preventing burn wound infections since the anti-infective effect of silver sulfadiazine (Ag-SD) was established in 1973 . Its systemic side effects are temporary leucopenia (SAL) that occurs early in the medication. However, the definition of SAL has not been established so far. because